Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: KEGG:D03345 (
beta-Galactosidase
)
434
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Adenoviruses are highly efficient vectors for gene transfer into brain cells. Restricting transgene expression to specific cell types and maintaining long-term expression are major goals for gene therapy in the central nervous system. We targeted gene expression to neurons by constructing an adenoviral vector that expressed the E. coli LacZ reporter gene under the control of the rat neuron-specific enolase promoter (Ad-
NSE
). Expression from Ad-
NSE
was compared with that from an adenoviral vector encoding the same reporter gene under the control of the Rous sarcoma virus LTR promoter (Ad-RSV). Both recombinant adenoviruses were injected stereotactically into rat hippocampus, cerebellum and striatum. Anatomical and immunohistochemical analyses of the Ad-
NSE
-stained cells showed that neurons were preferentially transduced. More neurons were stained in the hippocampus following infection with Ad-
NSE
than with Ad-RSV. Cytotoxicity from Ad-
NSE
was lower than from Ad-RSV.
beta-Galactosidase
gene expression after Ad-
NSE
infection remained stable for 3(1/2) months, and was detectable for 6 months. Thus, the
NSE
-adenoviral vector can be used to transfer potentially therapeutic genes into neuronal cells. The use of a cell-specific promoter also resulted in high in vivo efficiency and long-term transgene expression.
...
PMID:Efficient gene transfer and long-term expression in neurons using a recombinant adenovirus with a neuron-specific promoter. 1060 84